This segment focuses on the research, development, manufacturing, and commercialization of blood purification devices and adsorption products. Jafron's core technology centers around hemoperfusion and hemoadsorption, utilizing specialized columns and cartridges to remove toxins and harmful substances from the blood. R&D activities include the development of new adsorbent materials, improved device designs, and clinical trials to demonstrate efficacy and safety in various therapeutic areas. Technologies employed include porous polymeric beads and advanced filtration methods. The primary therapeutic areas addressed are kidney disease, liver disease, critical illnesses, and poisoning. These products aim to improve patient outcomes by reducing the severity of symptoms and supporting organ function. Jafron holds a strong market position in China and is expanding globally, with competitive advantages stemming from its proprietary technologies and established distribution networks. Future opportunities lie in expanding product lines, entering new markets, and developing innovative solutions for unmet medical needs. Regulatory compliance and clinical validation are critical aspects of this segment, with products requiring approvals from various health authorities. Jafron collaborates with international experts and institutions to enhance its research and clinical programs.